The findings suggest that the HER2DX assay could help clinicians decide on the appropriate use of chemotherapy in older patients, study researchers wrote.

Regorafenib-nivolumab “was not superior to investigator’s choice of chemotherapy in third- or later-line treatment,” said David Goldstein, MBBS.

A scoping review identified key factors that ensure an optimal nursing work environment that supports nurses and quality patient care.

Researchers recommend that future studies examine potential associations between survival and genomic mutations, clinical treatment history, and area deprivation index.

A retrospective study investigated the association of biomarkers pre- and post-cilta cel infusion with neurocognitive TEAEs and cranial nerve palsy in pts with RRMM.

Increase in cultivated land and herbicide-treated acreage independently linked to increase in melanoma incidence.

Cardiac testing identified asymptomatic, clinically significant arrhythmias in 19% of patients on ibrutinib.

Researchers studied the effect of a second primary melanoma on overall survival among patients with a previous cutaneous or non-cutaneous melanoma.

HealthDay News — Commonly used noncancer medications, including proton pump inhibitors, are associated with poorer survival and adverse events for patients with breast cancer, according to a study ...

Pemigatinib was well-tolerated among patients with CCA regardless of presence of CUP, but HCRU costs were higher with CUP vs without CUP.

Perioperative enfortumab vedotin and pembrolizumab added to surgery may represent a new standard of care in this population with a high unmet medical need,” said Christof Vulsteke, MD, PhD.

Supervised aerobic, resistance exercise tied to improved lean mass, muscle strength, and physical performance.